BD Veritor™ Plus System
for Rapid Detection of
Group A Strep

The BD Veritor™ Plus System test for Group A Strep for simple streptococcus testing, with results delivered in just 5 minutes.

 

Contact Us

 

BD Veritor All Assays

Efficient Group A Strep testing.

The BD Veritor™ Plus System is designed to offer simple Group A Strep testing, with results delivered in just 5 minutes.

White and orange packing box with blue lettering for BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 & Flu A+B test

BD Veritor™ Plus System for Rapid Detection of Group A Strep (CLIA-waived kit) offers proven performance vs culture

 

Sensitivity

Specificity

Results in

Throat swab sample

96.6%

(95% CI: 92.4%, 98.6%)

95.5%

(95% CI: 93.6%, 96.9%)

 

5 minutes

 

 

Ordering information

Cat no.

Qty

BD Veritor™ Plus System Group A Strep kit

256040

30 tests

BD Veritor™ Plus Analyzer

256066

1 unit

Get more answers with every sample.

Content Card Image

Simplifies the testing process

  • Easy operation with single-button functionality that can potentially reduce manual test processing errors
  • Provides intuitive sample processing with prefilled, unitized tubes
Content Card Image

Delivers workflow efficiency

Adapts easily to your workflow by offering 2 operational modes

  • Walk Away: the test device is inserted into the Analyzer immediately after preparation, allowing staff to multitask while the sample incubates
  • Analyze Now: the test device is inserted after the incubation time is complete, allowing batches of samples to be tested at once
Content Card Image

Provides results traceability

  • Downloadable lot number, patient/specimen ID, operator ID entry capability and test records with the BD Veritor™ InfoWiFi module or via the companion ImageMover application
  • Offers result printing capabilities via USB port
Content Card Image

Achieves reliable, rapid results

  • Displays easy-to-read digital results for Group A Strep in just 5 minutes1
  • Provides clear, objective results by correcting for nonspecific binding and detecting faint lines not recognized by the unaided eye5

Contact a Sales Representative to get your organization’s

diagnostic testing program started today

BD Veritor™ Plus System Support & Training

See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.

Reimbursement May Be Available Now

Your questions about reimbursement, answered.

1. BD Veritor™ Plus System for Rapid Detection of Group A Strep. Package insert. 8087667 Becton, Dickinson and Company.

BD Life Sciences, 7 Loveton Circle, Sparks, MD 21152-0999 USA 800-638-8663

*EUA Information for the BD Veritor™ SARS-CoV-2 and SARS-CoV-2 & Flu A+B assays: These products have not been FDA cleared or approved; but have been authorized by FDA under EUA for use by authorized laboratories. The BD Veritor™ System for Rapid Detection of SARS-CoV-2 has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, the emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.